Emtricitabine
Who holds supplier records for Emtricitabine? 11 organisations hold a current record for Emtricitabine: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (8) and China (2); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Emtricitabine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/emtricitabine
Reading the evidence
- 11 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
8 of the 10 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 6 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (11)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Emtricitabine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 27455, 19566, 31457 · latest filing Mar 2017
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 20708, 43664 · latest filing Mar 2026
- Hetero Labs LimitedIndia Company GMP cert on recordActive DMF 33068, 21612 · latest filing Oct 2018
- Arene Life Sciences LimitedIndiaActive DMF 34105 · latest filing Oct 2019
- Cipla LimitedIndia Company GMP cert on recordActive DMF 19785 · latest filing Sept 2006
- Laurus Labs LimitedIndia Company GMP cert on recordActive DMF 23773 · latest filing Apr 2010
- Lupin LimitedIndia Company GMP cert on recordActive DMF 22944 · latest filing Sept 2009
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 25001 · latest filing May 2011
- Shanghai Desano Chemical Pharmaceutical Co., LtdChinaActive DMF 25617 · latest filing Dec 2011
- Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd.ChinaActive DMF 24975, 42557 · latest filing Oct 2025
- VIVIN DRUGS AND PHARMACEUTICALS LTDActive DMF 32096 · latest filing Nov 2017
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (3)
Organisations whose Type II DMFs for Emtricitabine are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- India · Inactive DMF 28505 · filed Aug 2014
- India · Inactive DMF 23184 · filed Oct 2009
- RANBAXY LABORATORIES LTDInactive DMF 21706 · filed Jun 2008
Overview
Emtricitabine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL885).
Chemical identity
- IUPAC name
- 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
- Canonical SMILES
- C1[C@H](O[C@H](S1)CO)N2C=C(C(=NC2=O)N)F
- InChIKey
- XQSPYNMVSIKCOC-NTSWFWBYSA-N
- Synonyms
- 524-W-91, 524W91, BW-524W91, Coviracil, Emtricitabina, (-)-emtricitabine, Emtricitabine, Emtricitabine, (-)-, Emtricitabine component of atripla, Emtricitabine component of biktarvy, Emtricitabine component of complera, Emtricitabine component of descovy
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- Mechanism of action
- Nucleoside Reverse Transcriptase Inhibitors
- Chemical structure
- Nucleosides
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Emtricitabine?
11 organisations hold an active US FDA Type II Drug Master File or a CEP for Emtricitabine: MATRIX PHARMACORP PRIVATE LTD (India), APITORIA PHARMA PRIVATE LTD (India), Hetero Labs Limited (India), Arene Life Sciences Limited (India), Cipla Limited (India), Laurus Labs Limited (India), Lupin Limited (India) and Macleods Pharmaceuticals Ltd. (India), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Emtricitabine Drug Master Files are active?
MATRIX PHARMACORP PRIVATE LTD (DMF 27455, 19566), APITORIA PHARMA PRIVATE LTD (DMF 20708, 43664), Hetero Labs Limited (DMF 33068, 21612), Arene Life Sciences Limited (DMF 34105), Cipla Limited (DMF 19785), Laurus Labs Limited (DMF 23773), Lupin Limited (DMF 22944) and Macleods Pharmaceuticals Ltd. (DMF 25001) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Emtricitabine records mean?
3 organisations have only inactive Type II DMFs for Emtricitabine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Emtricitabine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Emtricitabine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.